Inventor · disambiguated record
Jeffrey Johnson
Also filed as: JOHNSON JEFFREY · JOHNSON JEFFREY S
4 granted patents·7 pending applications·151 citations·filing 1999–2012
80Inventor score
Files withDUMAS JACQUES5BAYER AG1BAYER HEALTHCARE LLC1BAYER PHARMACEUTICALS CORP1HENTEMANN MARTIN F1
Top patents by PatentIndex Score
11 records- 0196US7625915B2Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureasBAYER HEALTHCARE LLC·Filed 2007·Granted Dec 1, 2009·33 cites·1 claims
- 0294US7329670B1Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureasBAYER PHARMACEUTICALS CORP·Filed 1999·Granted Feb 12, 2008·76 cites·7 claims
- 0383US6353006B1Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agentsBAYER AG·Filed 1999·Granted Mar 5, 2002·33 cites·7 claims
- 0479US8859572B2Sulfone substituted 2,3-dihydroimidazo [1,2-C] quinazoline derivatives useful for treating hyper-proliferative disorders and diseases with angiogenesisHENTEMANN MARTIN F·Filed 2009·Granted Oct 14, 2014·9 cites·16 claims
- 0561US2008300281A1Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic UreasDUMAS JACQUES·Filed 2008·Application pending·0 cites
- 0659US2007244120A1Inhibition of raf kinase using substituted heterocyclic ureasDUMAS JACQUES·Filed 2007·Application pending·0 cites
- 0755US2012046290A1Inhibition of p38 kinase activity using substituted heterocyclic ureasDUMAS JACQUES·Filed 2007·Application pending·0 cites
- 0853US2012129893A1Inhibition Of Raf Kinase Using Substituted Heterocyclic UreasDUMAS JACQUES·Filed 2012·Application pending·0 cites
- 0947US2012149706A1Inhibition of p38 kinase activity using substituted heterocyclic ureasDUMAS JACQUES·Filed 2012·Application pending·0 cites
- 1041US2003207865A1Substituted 2-arylimino heterocycles and compositions containing them for use as progesterone receptor binding agentsFiled 2001·Application pending·0 cites
- 1137US2004267017A13-pyridyl or 4-isoquinolinyl thiazoles as c17, 20 lyase inhibitorsFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeffrey Johnson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →